BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21882827)

  • 1. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
    Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
    J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
    Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
    J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
    Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
    ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
    Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
    Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.
    Luo Y; Knuckley B; Lee YH; Stallcup MR; Thompson PR
    J Am Chem Soc; 2006 Feb; 128(4):1092-3. PubMed ID: 16433522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
    Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
    Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
    Subramanian V; Knight JS; Parelkar S; Anguish L; Coonrod SA; Kaplan MJ; Thompson PR
    J Med Chem; 2015 Feb; 58(3):1337-44. PubMed ID: 25559347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
    Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils cast NETs in atherosclerosis: employing peptidylarginine deiminase as a therapeutic target.
    Döring Y; Soehnlein O; Weber C
    Circ Res; 2014 Mar; 114(6):931-4. PubMed ID: 24625721
    [No Abstract]   [Full Text] [Related]  

  • 10. The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.
    Öğüten PN; Engür Öztürk S; Dikmen M
    Medicine (Baltimore); 2024 Feb; 103(8):e37015. PubMed ID: 38394536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines.
    Tang W; Li H; Poulos TL; Silverman RB
    Biochemistry; 2015 Apr; 54(15):2530-8. PubMed ID: 25811913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein arginine deiminase 4: a target for an epigenetic cancer therapy.
    Slack JL; Causey CP; Thompson PR
    Cell Mol Life Sci; 2011 Feb; 68(4):709-20. PubMed ID: 20706768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
    Ahmed D; Puthussery H; Basnett P; Knowles JC; Lange S; Roy I
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
    Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
    J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings.
    Jang B; Kim HW; Kim JS; Kim WS; Lee BR; Kim S; Kim H; Han SJ; Ha SJ; Shin SJ
    J Leukoc Biol; 2015 Feb; 97(2):351-62. PubMed ID: 25420918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.
    Li D; Liu C; Lin J
    J Mol Graph Model; 2015 Feb; 55():25-32. PubMed ID: 25424656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
    Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
    Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.
    Bicker KL; Anguish L; Chumanevich AA; Cameron MD; Cui X; Witalison E; Subramanian V; Zhang X; Chumanevich AP; Hofseth LJ; Coonrod SA; Thompson PR
    ACS Med Chem Lett; 2012 Oct; 3(12):1081-1085. PubMed ID: 23420624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells.
    Jang B; Ishigami A; Kim YS; Choi EK
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antitumor activity of new deaza analogues of the nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523).
    Vaidya CM; Wright JE; Rosowsky A
    J Med Chem; 2002 Apr; 45(8):1690-6. PubMed ID: 11931624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.